Nasdaq

Chembio Diagnostics Announces Appointment of Larry Steenvoorden as Chief Financial Officer

HAUPPAUGE, N.Y., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the appointment ...
Newsday

Chembio merger in doubt as shareholders refuse to sell their stock

Shareholders of Chembio Diagnostics Inc. haven’t yet agreed to a proposed merger with a French firm, despite warnings that the Medford test maker could file for bankruptcy or even close permanently if ...
Seeking Alpha

Biosynex Completes Acquisition of Chembio Diagnostics, Inc.

Chembio Diagnostics, Inc. (CEMI) becomes the first North American structure controlled by Biosynex in North America STRASBOURG, France, April 27, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA ...
Nasdaq

Chembio Diagnostics (NASDAQ:CEMI) Is Making Moderate Use Of Debt

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it seems ...
CNN

Chembio Diagnostics Announces Closing of Public Offering of Common Stock

HAUPPAUGE, N.Y., May 11, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio”), a leading point-of-care diagnostic company focused on infectious diseases, announced today the ...
Seeking Alpha

Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement

STRASBOURG, France and HAUPPAUGE, N.Y., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, and ...
Business Insider

Chembio Diagnostics Announces Completion of U.S. Clinical Trial Evaluating DPP® HIV-Syphilis SystemU.S. Regulatory Submission for DPP® HIV-Syphilis System Expected in Q1 2018

MEDFORD, N.Y., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced completion of the ...
Benzinga.com

Chembio Diagnostics And 2 Other Stocks Under $1 Insiders Are Aggressively Buying

The Dow Jones closed higher by around 380 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders ...
pix11

Chembio Diagnostics Announces Election of Leslie Teso-Lichtman to Its Board of Directors

HAUPPAUGE, N.Y., May 24, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Chembio) (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the ...
Newsday

Chembio Diagnostics settles with SEC as sale to Biosynex nears

A manufacturer of rapid diagnostic tests in Hauppauge has paid $500,000 to end an investigation by the U.S. Securities and Exchange Commission, according to a securities filing. Chembio Diagnostics ...
Business Insider

Chembio Diagnostics Appoints Christine Rousseau, Ph.D. as Vice President, Corporate Development

MEDFORD, N.Y., July 19, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic testing, today announced the appointment of Christine M. Rousseau ...
CNN

Chembio Diagnostics Announces Pricing of Public Offering of Common Stock

HAUPPAUGE, N.Y., May 07, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio”), a leading point-of-care diagnostic company focused on infectious diseases, announced today the ...